| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.3M | -15.4% |
| Cost of Revenue | $16.3M | +27.2% |
| R&D Expense | $46.3M | -21.4% |
| SG&A Expense | $55.1M | +3.6% |
| Operating Income | -$58.5M | +14.0% |
| Pre-tax Income | -$65.2M | +14.3% |
| Income Tax | $34K | -50.7% |
| Net Income | -$65.3M | +14.4% |
| EPS (Basic) | -$0.89 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.3M | -70.4% |
| Short-term Investments | $54.2M | — |
| Inventory | $1.8M | -33.0% |
| Current Assets | $98.8M | +5.7% |
| Total Assets | $149.0M | +9.1% |
| Current Liabilities | $23.6M | -34.0% |
| Long-term Debt | $28.9M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.4M | +6.1% |
| Capital Expenditures | $4.3M | -2.6% |
| Investing Cash Flow | -$57.0M | -1072.9% |
| Financing Cash Flow | $60.5M | +641.1% |
| Free Cash Flow | -$53.7M | +5.9% |
| +20.5% |
| EPS (Diluted) | -$0.89 | +20.5% |
| Total Liabilities |
| $82.1M |
| +64.3% |
| Stockholders' Equity | $66.9M | -22.7% |